Replies to post #234892 on Biotech Values

[DewDiligence]

Back story on the BBIO-EIDX deal—how BBIO may have left a lot of money on the table:

https://www.evaluate.com/vantage/articles/news/corporate-strategy/bridgebio-u-turn-shows-how-money-can-be-made-twice-over